South Korea as well as the US stay the business's Major marketplaces, but 3billion is trying to concentrate on "anyone who desires our companies at this stage," Keum claimed. The firm, Launched in Oct 2016 as a by-product from Korean genomic providers supplier Macrogen, has previously lifted revenue from the personal equity marketplace this 12